Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohammed M, Abuelmagd"'
Autor:
Ayman Maher Nagib, Zoheer A Fayyad, Nabil Abdelfadil Elserwy, Mohamed Abdel Monem, Mahmoud Mohamed Khaled, Zakaria Zakaria, Amro M Mahmoud, Khaled A Atea, Ahmed S Draz, Ahmed Y Mostafa, Mohamed A Hammad, Medhat A Halim, Prasad Nair, Mohammed M Abuelmagd, Mohamed Shaker, Mohamed E Ameenn, Mohammed Adel, Tarek Mahmoud, Osama Gheith, Ahmed K Alqallaf, Torki Al-Otaibi, Ahmad Abbas, Hasaneen H Aboatya, Ahmed F Atta
Publikováno v:
Clinical Transplantation
Introduction COVID‐19 is an ongoing pandemic with high morbidity and mortality and with a reported high risk of severe disease in kidney transplant recipients (KTR). Aim We aimed to report the largest number of COVID‐19‐positive cases in KTR in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5af02d5f2856d9ebc026a895eaa09f3
https://pubmed.ncbi.nlm.nih.gov/33768630
https://pubmed.ncbi.nlm.nih.gov/33768630
Autor:
Mohammed M Abuelmagd, Mohamed Hamed Abbas, M.A. Bakr, Ayman F. Refaie, Ahmed Abdelfattah Denewar, Ahmed H Neamatalla, Ayman Maher Nagib
Publikováno v:
Transplantation Proceedings. 47:1099-1104
Objectives. Steroids have played a major role in renal transplantation for more than 4 decades. However, chronic use of steroids is associated with many comorbidities. This study aimed to assess the costs and benefits of a steroid-free immunosuppress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa297c2d28da54ff32cda0a3bf86d1b4
https://doi.org/10.1016/j.transproceed.2014.11.063
https://doi.org/10.1016/j.transproceed.2014.11.063
Autor:
Y.A. Elhindi, M.A. Bakr, M.H. Ali, Megahed M. Abuelmagd, H.M. Elmaghrabi, M.F. Ahmed, Ayman F. Refaie, Mohammed M Abuelmagd, Ayman Maher Nagib
Publikováno v:
Transplantation Proceedings. 47:1152-1157
Objectives Kidney donors, similar to the general population, are at risk for developing type 2 diabetes mellitus (T2DM). The course of donors who develop T2DM has not been well studied. This work estimates the incidence of diabetes after kidney donat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1d12e7b00897b2e64ba2729bf9daa9
https://doi.org/10.1016/j.transproceed.2014.11.064
https://doi.org/10.1016/j.transproceed.2014.11.064
Autor:
Yasser Elsayed Matter, Ayman Maher Nagib, Mohamed Hamed Abbas, Ahmed Farouk Donia, Ahmed Maher Alsayed, Ahmed A. Shokeir, Ahmed Akl, Ayman F. Refaie, Hussein Atia Shaeashaa, Omar E Lotfy, Mohammed M Abuelmagd
Publikováno v:
Nephro-urology Monthly
Background Renal transplantation is the ideal method for management of end-stage renal disease. The use of living donors for renal transplantation was critical for early development in the field and preceded the use of cadaveric donors. Most donors a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f514062fc99706c34fedecdf97c6f3f9
https://doi.org/10.5812/numonthly.34770
https://doi.org/10.5812/numonthly.34770
Autor:
Mohammed M, Abuelmagd, Ayman M, Nagib, Megahed M, Abuelmagd, Ayman F, Refaie, Yasser A, Elhindi, Mohammed F, Ahmed, Mohammed H, Ali, Hanzada M, Elmaghrabi, Mohammed A, Bakr
Publikováno v:
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 13
Kidney donors, similar to the general population, are at risk for development of type 2 diabetes mellitus. The course of donors who develop type 2 diabetes mellitus has not been well studied. This work is aimed at estimating the incidence of diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2cc5f44791199314de05ce620bb729af
https://pubmed.ncbi.nlm.nih.gov/25894138
https://pubmed.ncbi.nlm.nih.gov/25894138